Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
FASEB J ; 21(7): 1503-14, 2007 May.
Artigo em Inglês | MEDLINE | ID: mdl-17255471

RESUMO

Sphingosine-1-phosphate (S1P) acts as an extracellular ligand for a family of G-protein coupled receptors that are crucial in cell migration. S1P5 is exclusively expressed in oligodendrocytes and oligodendrocyte precursor cells (OPCs), which migrate considerable distances during brain development. The current studies suggest a physiological role for S1P and S1P5 in regulation of OPC migration. mRNA expression levels of S1P2 and S1P5 are comparable in OPCs, but S1P binding specifically to the S1P5 receptor blocked OPC migration (IC50=29 nM). Thus, knocking down S1P5 using siRNA prevented the S1P-induced decrease in OPC migration, whereas knocking down S1P2 did not have any effect. S1P-induced modulation of OPC migration was insensitive to pertussis toxin, suggesting that S1P5-initiated signaling is not mediated by the G alpha(i)-protein coupled pathway. Furthermore, S1P5 appears to engage the G alpha(12/13) protein coupled Rho/ROCK signaling pathway to impede OPC migration. To modulate OPC motility, extracellular S1P could be derived from the export of intracellular S1P generated in response to glutamate treatment of OPCs. These studies suggest that S1P could be a part of the neuron-oligodendroglial communication network regulating OPC migration and may provide directional guidance cues for migrating OPCs in the developing brain.


Assuntos
Movimento Celular , Oligodendroglia/citologia , Receptores de Lisoesfingolipídeo/metabolismo , Animais , Sequência de Bases , Movimento Celular/efeitos dos fármacos , Técnicas de Cocultura , Primers do DNA , Inativação Gênica , Ácido Glutâmico/farmacologia , Lisofosfolipídeos/farmacologia , RNA Mensageiro/genética , Ratos , Receptores de Lisoesfingolipídeo/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Espectrometria de Massas por Ionização por Electrospray , Esfingosina/análogos & derivados , Esfingosina/farmacologia , Espectrometria de Massas em Tandem
2.
FEBS Lett ; 580(26): 6047-54, 2006 Nov 13.
Artigo em Inglês | MEDLINE | ID: mdl-17064696

RESUMO

Previous work has identified sphingosine kinase-1 (SK1) as a substrate for the cysteine protease cathepsin B in vitro. In this study, the mechanism of SK1 cleavage by cathepsin B was investigated. We identified two initial cleavage sites for the protease, the first at histidine 122 and the second at arginine 199. Mutation analysis showed that replacement of histidine 122 with a tyrosine maintained the activity of SK1 while significantly reducing cleavage by cathepsin B at the initial cleavage site. The efficacy of cleavage of SK1 at arginine 199, however, was not affected. These studies demonstrate that SK1 is cleaved by cathepsin B in a sequential manner after basic amino acids, and that the initial cleavages at the two identified sites occur independently of each other.


Assuntos
Catepsina B/metabolismo , Fosfotransferases (Aceptor do Grupo Álcool)/metabolismo , Aminoácidos Básicos , Arginina , Sítios de Ligação , Linhagem Celular Tumoral , Histidina , Humanos , Mutagênese Sítio-Dirigida , Transfecção
3.
Pharmacol Ther ; 112(1): 171-83, 2006 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-16759708

RESUMO

Inflammation is viewed as a protective response against insults to the organism. It involves the recruitment of many cell types and the production of various inflammatory mediators in attempts to contain and reverse the insult. However, inflammation can lead to irreversible tissue destruction by itself and, therefore, can represent a disease state that causes significant morbidity and mortality. Understanding the molecular mechanisms controlling the inflammatory response is essential to formulate therapeutic strategies for the treatment of inflammatory conditions. In fact, substantial research has unveiled important aspects of the inflammatory machinery, both at the cellular and molecular levels. Recently, sphingolipids (SLs) have emerged as signaling molecules that regulate many cell functions, and ample evidence emphasizes their role in the regulation of inflammatory responses. Here, we review the role of bioactive SL as regulators and mediators of inflammatory responses.


Assuntos
Inflamação/metabolismo , Esfingolipídeos/metabolismo , Animais , Ciclo-Oxigenase 2/metabolismo , Citocinas/metabolismo , Cloridrato de Fingolimode , Humanos , Imunossupressores/farmacologia , Inflamação/imunologia , Lipopolissacarídeos/farmacologia , Fosfolipases A/metabolismo , Propilenoglicóis/farmacologia , Prostaglandinas/metabolismo , Esfingolipídeos/imunologia , Esfingosina/análogos & derivados , Esfingosina/farmacologia
4.
FASEB J ; 20(3): 482-4, 2006 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-16507765

RESUMO

Activation of sphingosine kinase-1 (SK1) by overexpression or agonist stimulation promotes cell proliferation, survival, and anti-apoptosis. Studies on the function of endogenous SK1 are lacking. Endogenous SK1 has been shown to be down-regulated under stress, and knockdown of the enzyme reduces the percentage of viable MCF-7 breast cancer cells (Taha, T. A. et al. 2004. J. Biol. Chem. 279, 20546-20554). In this study, we examined the mechanisms by which SK1 loss affects the growth of cells. Knockdown of the enzyme by small interfering RNA caused cell cycle arrest and induced apoptosis. Cell death involved effector caspase activation, cytochrome c release and Bax oligomerization in the mitochondrial membrane, thus placing SK1 knockdown upstream of the mitochondrial pathway of apoptosis. SK1 knockdown also induced significant increases in ceramide levels in whole cells and in mitochondria enriched fractions of cells. Inhibition of de novo sphingolipid biosynthesis with myriocin significantly attenuated Bax oligomerization and downstream caspase activation after SK1 loss. These studies for the first time implicate endogenous SK1 as an important survival enzyme in MCF-7 cells and link the biological consequences of knocking down the enzyme to its biochemical role as a regulator of sphingolipid metabolism.


Assuntos
Apoptose/fisiologia , Fosfotransferases (Aceptor do Grupo Álcool)/fisiologia , Esfingolipídeos/metabolismo , Adenocarcinoma/patologia , Neoplasias da Mama/patologia , Caspases/metabolismo , Ciclo Celular , Linhagem Celular Tumoral/efeitos dos fármacos , Linhagem Celular Tumoral/metabolismo , Ceramidas/metabolismo , Citocromos c/fisiologia , Ativação Enzimática , Ácidos Graxos Monoinsaturados/farmacologia , Feminino , Marcação de Genes , Humanos , Mitocôndrias/fisiologia , Proteínas de Neoplasias/deficiência , Proteínas de Neoplasias/fisiologia , Fosfotransferases (Aceptor do Grupo Álcool)/deficiência , RNA Mensageiro/antagonistas & inibidores , RNA Interferente Pequeno/farmacologia , Esfingolipídeos/biossíntese , Proteína X Associada a bcl-2/fisiologia , Proteína bcl-X/fisiologia
5.
Prostaglandins Other Lipid Mediat ; 78(1-4): 249-63, 2005 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-16303620

RESUMO

Sphingolipids (SLs) have a biomodulatory role in physiological as well as pathological cardiovascular conditions. This study aims to assess the variation of SL mediators and metabolizing enzymes in the growing and hypoxic rat heart. Sprague-Dawley rats were placed in a hypoxic environment at birth. Control animals remained in room air. In control animals, activities of acidic-sphingomyelinase (A-SMase), sphingomyelin synthase (SMS), glucosylceramide synthase (GCS), and ceramidase decreased with age in both ventricles whereas activity of neutral-sphingomyelinase (N-SMase) increased with age. Hypoxic RV mass was 171 and 229% that of controls, at 4 and 8 weeks, respectively. This was accompanied by an increase in RV myocardial ceramide synthesis, consumption and breakdown, with a net effect of suppression of ceramide accumulation and increase in diacylglycerol (DAG) concentration. In addition, significant increase in activities of: A-SMase by 26 and 29%, SMS by 108 and 40%, and ceramidase by 66 and 35%, in the hypoxic RV rats as compared to controls, was noted at 4 and 8 weeks of age, respectively. Sphingolipids and their regulating enzymes appear to play a role in adaptive responses to chronic hypoxia in the neonatal rat heart.


Assuntos
Hipóxia/metabolismo , Miocárdio/metabolismo , Transdução de Sinais , Esfingolipídeos/metabolismo , Amidoidrolases/metabolismo , Animais , Peso Corporal , Ceramidases , Glucosiltransferases/metabolismo , Hematócrito , Miocárdio/enzimologia , Tamanho do Órgão , Ratos , Ratos Sprague-Dawley , Transferases (Outros Grupos de Fosfato Substituídos)/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA